Ion Beam Applications SA (IOBCF) Q2 2025 Earnings Conference Call Transcript

2025-08-28 15:08:50 ET

Ion Beam Applications SA (IOBCF)

Q2 2025 Earnings Call

August 28, 2025, 09:00 AM ET

Company Participants

Catherine Vandenborre - Chief Financial Officer & Corporate Lead

Henri de Romree - Deputy CEO, Internal Director & Managing Director

Olivier Legrain - CEO, MD & Executive Director

Thomas Pevenage - Corporate Participant

Conference Call Participants

David Vagman - ING Groep N.V., Research Division

Laura Roba - Banque Degroof Petercam S.A., Research Division

Michiel Declercq - KBC Securities NV, Research Division

Presentation

Thomas Pevenage

Hello, everyone, and welcome to the presentation of IBA's results for the first half of 2025. I am Thomas Pevenage, Head of Investor Relations. As usual, you will find this presentation on the Investor Relations page of our website. A question-and-answer session will follow the formal presentation.

Moving to the next page, let me draw your attention to the company's disclaimer for forward-looking statements, which, as you know, are based on our current assumptions and beliefs and subject to risks and uncertainties. Today's speakers are Olivier Legrain, our Chief Executive Officer and IBA Clinical Lead; Henri de Romree, our Deputy Chief Executive Officer and IBA Technologies Lead, and we are pleased to welcome Catherine Vandenborre, our newly appointed Chief Financial Officer and IBA Corporate Leads....

Read the full article on Seeking Alpha

For further details see: